Early tests show that a new biologic is effective against serious infection.

Published Date: 26 Apr 2023

study participants included Janssen Biotech, Inc. and the NYU Grossman School of Medicine. have demonstrated in preliminary studies that a bioengineered drug candidate can prevent infection caused by the highly resistant bacterial species Staphylococcus aureus.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

2.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

3.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

4.

Charles III, King of Kings, is Cancerous.

5.

The Truth About Apple AirPods


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot